Physician profile
Christopher Lau
NPI 1255642831
$469.86
in general payments reported to CMS, 2019-2025
11 companies · $53.02 in 2025
The $53.02 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $16.78 · 2021: $15.61 · 2022: $120 · 2023: $51.90 · 2024: $60.41 · 2025: $53.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147 · Education: $18.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.05 |
| Education | $18.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $76.73 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $67.24 | 2023-2024 | Uptravi |
| Pulmonx Corporation | $66.94 | 2022 | |
| Resmed Corp | $56.57 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.80 | 2024-2025 | Ofev, Jascayd |
| Insmed, INC. | $38.01 | 2025 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $36.00 | 2019 | |
| Mallinckrodt Hospital Products INC. | $26.81 | 2022 | |
| Baxter Healthcare | $25.87 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.28 | 2023 | |
| Philips North America LLC | $15.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.